B3GAT1 and neuropathy: The anti-HNK1 ELISA has high sensitivity (98%) and specificity (99%) in the diagnosis of anti-MAG neuropathy, and anti-HNK1 titers are correlated to the disease severity, suggesting that this test could be used as an outcome measure in clinical trials [43].